Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

Bullboard Posts
Comment by PoorOpinionon Dec 13, 2018 10:17am
80 Views
Post# 29109265

RE:RE:RE:Positive Date From Phase 1b/2

RE:RE:RE:Positive Date From Phase 1b/2Not only that but the t-cell production is much lower in the 300mg group compared to 100mg. See the last page in the new presentation

https://ir.imv-inc.com/static-files/baa165d7-7db9-41c7-9296-c066fa214265

Maybe not a significant difference(just chance) but potential that epacadostat is inhibiting dpx MOA to some extent?????
Bring on the monotherapy data.


Breakthorough1 wrote:
Much less clinical benefit in the higher dose of Epacadostat (even if the action of this drug is seen to increase with the dose).


Bullboard Posts